Alto Neuroscience, Inc. is a clinical-stage biopharmaceutical company focused on precision psychiatry. It develops biomarker-driven psychiatric treatments using its proprietary Precision Psychiatry Platform, which integrates EEG, neurocognitive assessments, wearable devices, and genomic data with machine learning analytics. Its seven clinical-stage pipeline assets target MDD, bipolar depression, TRD, schizophrenia, and Parkinson's disease, with lead candidate ALTO-207 (a fixed-dose combination of pramipexole and ondansetron) for TRD and ALTO-300 (agomelatine) for MDD.
expected 2026-11-26
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-16 | 2025-12-31 | 0001999480-26-000002 | EDGAR | 122K words |
| 2025-03-20 | 2024-12-31 | 0001999480-25-000025 | EDGAR | 115K words |
| 2024-03-21 | 2023-12-31 | 0001999480-24-000010 | EDGAR | 139K words |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-12 | 2026-06-30 | 0001999480-26-000023 | EDGAR | 25K words |
| 2025-11-12 | 2025-09-30 | 0001999480-25-000090 | EDGAR | 25K words |
| 2025-08-13 | 2025-06-30 | 0001999480-25-000076 | EDGAR | 24K words |
| 2025-05-14 | 2025-03-31 | 0001999480-25-000037 | EDGAR | 24K words |
| 2024-11-12 | 2024-09-30 | 0001999480-24-000042 | EDGAR | 77K words |
| 2024-08-13 | 2024-06-30 | 0001999480-24-000035 | EDGAR | 75K words |
| 2024-05-14 | 2024-03-31 | 0001999480-24-000022 | EDGAR | 73K words |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-08-27 | 0001999480-26-000024 | EDGAR | 1K words |
| 2026-08-12 | 0001999480-26-000022 | EDGAR | 3K words |
| 2026-07-14 | 0001104659-26-083274 | EDGAR | 23K words |
| 2026-07-13 | 0001104659-26-082875 | EDGAR | 1K words |
| 2026-04-01 | 0001104659-26-038593 | EDGAR | 1K words |
| 2026-03-16 | 0001104659-26-027953 | EDGAR | 1K words |
| 2026-03-16 | 0001999480-26-000001 | EDGAR | 2K words |
| 2025-11-12 | 0001999480-25-000089 | EDGAR | 3K words |
| 2025-10-20 | 0001104659-25-100801 | EDGAR | 1K words |
| 2025-08-13 | 0001999480-25-000075 | EDGAR | 3K words |
44 total filings indexed. 24 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001999480 |
| Ticker | ANRO |
| Exchange | NYSE |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://www.altoneuroscience.com |
| Listed | 2024-02-02 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/ANRO (~200 tokens, structured JSON with cryptographic provenance)